ASCO GU 2019 Treatment and management of hormonesensitive metastatic prostate cancer

ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate cancer

22:10 EST 15 Feb 2019 | ecancermedicalscience

Professor Karim Fizazi and Professor Eleni Efstathiou set the scene in current care and discuss the treatment options available for hormone-sensitive metastatic prostate cancer, highlighting the unmet need in recurrent metastatic disease. New updates to...

More From BioPortfolio on "ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate cancer"